MiR-205-5P AS POTENTIAL BIOMARKER AND THERAPEUTIC TARGET IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

S. Babu; M. Krishnan; M. Chinnaiyan; P. Daniel; A. Solomon

Автор(и)

S. Babu Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, India
M. Krishnan Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, India
M. Chinnaiyan Department of Otolaryngology, University of Oklahoma Health Sciences Center, Oklahoma City, USA
P. Daniel Department of Medical Biochemistry, Dr. A.L.M PG Institute of Basic Medical Sciences, University of Madras, Chennai, Tamil Nadu, India
A. Solomon Department of Mental Health Nursing, Saveetha College of Nursing, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India

Ключові слова:

miRNA

Анотація

Посилання

Zhang LM, Su LX, Hu JZ, et al. Epigenetic regulation of VENTXP1 suppresses tumor proliferation via miR-205-5p/ANKRD2/NF-kB signaling in head and neck squamous cell carcinoma. Cell Death Dis 2020; 11: 838. doi: https://doi.org/10.1038/s41419-020-03057-w

Zhou Z, Liu C, Liu K, et al. Expression and possible molecular mechanisms of microRNA-205-5p in patients with head and neck squamous cell carcinoma. Technol Cancer Res Treat 2020; 19. doi: https://doi.org/10.1177/1533033820980110

Balihodzic A, Prinz F, Dengler MA, et al. Non-coding RNAs and ferroptosis: potential implications for cancer therapy. Cell Death Differ 2022; 29: 1094–106. doi: https://doi.org/10.1038/s41418-022-00998-x

Chen B, Dragomir MP, Yang C, et al. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther 2022; 7: 121. doi: https://doi.org/10.1038/s41392-022-00975-3

Robb T, Reid G, Blenkiron C. Exploiting microRNAs as cancer therapeutics. Target Oncol 2017; 12: 163–78. doi: 10.1007/s11523-017-0476-7

Koshizuka K, Hanazawa T, Fukumoto I, et al. The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma. J Hum Genet 2017; 62: 3–13. doi: https://doi.org/10.1038/jhg.2016.105

Zhuang L, Guo J, Yao Y, Li Z. miR-205 targets runt-related transcription factor 2 to inhibit human pancreatic cancer progression. Oncol Lett 2019; 17: 843–8. doi: https://doi.org/10.3892/ol.2018.9689

Tian L, Zhang J, Ge J, et al. MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma. Med Oncol 2014; 31: 785. doi: https://doi.org/10.1007/s12032-013-0785-3